Importantly, the natural compound partenolide was also effective at inducing the cytotoxic effects on CD133+ primary prostate tumor cells while CD133+ normal cells from benign prostate hyperplasia were insensitive to this treatment type in vitro[58]. The gene discussed is PROM1; the disease is benign prostatic hyperplasia.